BIO GREN MED SL (BGMS)
(Real Time Quote from BATS)
$4.45 USD
-0.63 (-12.40%)
Updated Sep 17, 2025 01:16 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About Market Cap
As of the previous market close, Cyclacel Pharmaceuticals, Inc. has a market cap of $11.37M, which represents its share price of $5.08 multiplied by its outstanding shares number of 2.24M. As a small-cap company, BGMS's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
BGMS 4.45 -0.63(-12.40%)
Will BGMS be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for BGMS based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for BGMS
12 Health Care Stocks Moving In Wednesday's Intraday Session
Lower Bollinger Band Walk appears for BGMS after 3.05% move
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
BGMS makes New 52 Week Closing Low on September 15
Bio Green Med Solution Faces Nasdaq Delisting Notice